Welcome to our newsroom. Here you will find all the latest news about Brystol Myers Squibb in the Netherlands. As a journalist, you will also find all press releases, contact details and visual material here.
Bristol Myers Squibb (BMS) has started the construction of its CAR T cell therapy production center at the Leiden Bio Science Park (LBSP). Leiden will be the biopharmaceutical company’s first cell therapy facility in Europe and the fifth in the world. BMS expects the facility to be operational at the end of 2024, bringing the manufacturing of its cell therapies closer to European patients. In addition, the new production facility is expected to create at least 500 new jobs.
Bristol Myers Squibb (BMS) announces the appointment of Sally Ann McNab as General Manager for Belgium, Luxembourg and The Netherlands, effective September 1st. Previously she was Vice President Worldwide Oncology Commercialisation at BMS.
For all media inquiries
Senior Manager Corporate Affairs
Phone number: +31 30 300 22 22
If you are not a member of the press and have a non-media related question then find the right contact information here. This will enable us to help you faster!
Learn more about the mission, vision and values of Bristol Myers Squibb the Netherlands